Logo image of NEXT.OL

NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:NEXT - NO0010629108 - Common Stock

1.508 NOK
+0.01 (+0.53%)
Last: 1/15/2026, 4:19:46 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NEXT. NEXT was compared to 55 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of NEXT have multiple concerns. NEXT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NEXT had negative earnings in the past year.
  • In the past year NEXT has reported a negative cash flow from operations.
  • In the past 5 years NEXT always reported negative net income.
  • In the past 5 years NEXT always reported negative operating cash flow.
NEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFNEXT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

  • With a Return On Assets value of -140.57%, NEXT is not doing good in the industry: 94.55% of the companies in the same industry are doing better.
  • NEXT has a worse Return On Equity (-252.42%) than 90.91% of its industry peers.
Industry RankSector Rank
ROA -140.57%
ROE -252.42%
ROIC N/A
ROA(3y)-41%
ROA(5y)-47.51%
ROE(3y)-52%
ROE(5y)-61.09%
ROIC(3y)N/A
ROIC(5y)N/A
NEXT.OL Yearly ROA, ROE, ROICNEXT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

  • Looking at the Gross Margin, with a value of 42.52%, NEXT is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • NEXT's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NEXT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.73%
GM growth 5Y17.56%
NEXT.OL Yearly Profit, Operating, Gross MarginsNEXT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

3

2. Health

2.1 Basic Checks

  • NEXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NEXT has been increased compared to 1 year ago.
  • The number of shares outstanding for NEXT has been increased compared to 5 years ago.
  • The debt/assets ratio for NEXT is higher compared to a year ago.
NEXT.OL Yearly Shares OutstandingNEXT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly Total Debt VS Total AssetsNEXT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -3.22, we must say that NEXT is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -3.22, NEXT is doing worse than 92.73% of the companies in the same industry.
  • NEXT has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.03, NEXT belongs to the best of the industry, outperforming 89.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.22
ROIC/WACCN/A
WACC8.49%
NEXT.OL Yearly LT Debt VS Equity VS FCFNEXT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that NEXT has no problem at all paying its short term obligations.
  • NEXT has a better Current ratio (2.08) than 70.91% of its industry peers.
  • NEXT has a Quick Ratio of 2.08. This is a bad value and indicates that NEXT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NEXT has a worse Quick ratio (0.64) than 87.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 0.64
NEXT.OL Yearly Current Assets VS Current LiabilitesNEXT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

  • NEXT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.85%.
  • NEXT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -71.79%.
  • The Revenue has been decreasing by -3.25% on average over the past years.
EPS 1Y (TTM)-98.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1214.4%
Revenue 1Y (TTM)-71.79%
Revenue growth 3Y12.14%
Revenue growth 5Y-3.25%
Sales Q2Q%-89.13%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEXT.OL Yearly Revenue VS EstimatesNEXT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NEXT.OL Yearly EPS VS EstimatesNEXT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • NEXT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEXT.OL Price Earnings VS Forward Price EarningsNEXT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEXT.OL Per share dataNEXT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • NEXT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NEXT BIOMETRICS GROUP AS

OSL:NEXT (1/15/2026, 4:19:46 PM)

1.508

+0.01 (+0.53%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-19
Earnings (Next)03-11
Inst Owners14.24%
Inst Owner ChangeN/A
Ins Owners7.13%
Ins Owner ChangeN/A
Market Cap180.75M
Revenue(TTM)20.59M
Net Income(TTM)-78.80M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.78
P/FCF N/A
P/OCF N/A
P/B 5.79
P/tB 6.16
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.17
BVpS0.26
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -140.57%
ROE -252.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.52%
FCFM N/A
ROA(3y)-41%
ROA(5y)-47.51%
ROE(3y)-52%
ROE(5y)-61.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y45.73%
GM growth 5Y17.56%
F-Score1
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.68%
Cap/Sales 8.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 0.64
Altman-Z -3.22
F-Score1
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)4.07%
Cap/Depr(5y)3.14%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1214.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-71.79%
Revenue growth 3Y12.14%
Revenue growth 5Y-3.25%
Sales Q2Q%-89.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-117.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.41%
OCF growth 3YN/A
OCF growth 5YN/A

NEXT BIOMETRICS GROUP AS / NEXT.OL FAQ

What is the ChartMill fundamental rating of NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NEXT.OL.


Can you provide the valuation status for NEXT BIOMETRICS GROUP AS?

ChartMill assigns a valuation rating of 0 / 10 to NEXT BIOMETRICS GROUP AS (NEXT.OL). This can be considered as Overvalued.


How profitable is NEXT BIOMETRICS GROUP AS (NEXT.OL) stock?

NEXT BIOMETRICS GROUP AS (NEXT.OL) has a profitability rating of 1 / 10.